Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Rigo

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 28, 2019
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysisLuca Nicosia, Ciro Franzese, Rosario Mazzola, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 29, 2019
Stereotactic body radiotherapy of central lung malignancies using a simultaneous integrated protection approach : A prospective observational studyRosario Mazzola, Ruggero Ruggieri, Vanessa Figlia, et al.
Expert Review of Anticancer Therapy|September 10, 2020
Prostate re-irradiation: current concerns and future perspectivesFrancesco Cuccia, Rosario Mazzola, Luca Nicosia, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2019
Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patientsLuca Nicosia, Rosario Mazzola, Michele Rigo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 6, 2023
Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicityLuca Nicosia, Paolo Ravelli, Michele Rigo, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 14, 2020
Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancerFrancesco Cuccia, Luca Nicosia, Rosario Mazzola, et al.
Journal of Clinical Medicine|November 26, 2022
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate CancerLuca Nicosia, Giovanna Trapani, Michele Rigo, et al.
In Vivo (Athens, Greece)|January 2, 2023
Stereotactic Body Radiotherapy for a Rare Case of Sinonasal Metastasis Arising from Renal Cell CancerFrancesco Cuccia, Edoardo Pastorello, Claudio Vitale, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2020
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastasesLuca Nicosia, Francesco Cuccia, Rosario Mazzola, et al.
Cancer Management and Research|September 27, 2022
Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels<sup>®</sup>: Toxicity and Efficacy Analysis on a Retrospective Series of 305 PatientsLuca Nicosia, Claudio Vitale, Francesco Cuccia, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 28, 2019
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysisLuca Nicosia, Ciro Franzese, Rosario Mazzola, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 29, 2019
Stereotactic body radiotherapy of central lung malignancies using a simultaneous integrated protection approach : A prospective observational studyRosario Mazzola, Ruggero Ruggieri, Vanessa Figlia, et al.
Expert Review of Anticancer Therapy|September 10, 2020
Prostate re-irradiation: current concerns and future perspectivesFrancesco Cuccia, Rosario Mazzola, Luca Nicosia, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2019
Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patientsLuca Nicosia, Rosario Mazzola, Michele Rigo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 6, 2023
Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicityLuca Nicosia, Paolo Ravelli, Michele Rigo, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 14, 2020
Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancerFrancesco Cuccia, Luca Nicosia, Rosario Mazzola, et al.
Journal of Clinical Medicine|November 26, 2022
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate CancerLuca Nicosia, Giovanna Trapani, Michele Rigo, et al.
In Vivo (Athens, Greece)|January 2, 2023
Stereotactic Body Radiotherapy for a Rare Case of Sinonasal Metastasis Arising from Renal Cell CancerFrancesco Cuccia, Edoardo Pastorello, Claudio Vitale, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2020
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastasesLuca Nicosia, Francesco Cuccia, Rosario Mazzola, et al.
Cancer Management and Research|September 27, 2022
Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels<sup>®</sup>: Toxicity and Efficacy Analysis on a Retrospective Series of 305 PatientsLuca Nicosia, Claudio Vitale, Francesco Cuccia, et al.
Pageof 5